Primary aldosteronism (PA) is one of the most common causes of secondary hypertension but remains largely unrecognized and untreated. The objective of this population-based cohort study was to understand the outcomes of a specialized clinic on rates of evaluation and treatment of PA in the context of secondary factors. Less than 1% of patients expected to have PA were ever formally diagnosed and treated. These findings suggest that a system-level approach to assist with investigation and treatment of PA may be highly effective in closing care gaps and improving clinical outcomes.
Authors: Yuan-yuan Liu, James King, Gregory A. Kline, Raj S. Padwal, Janice L. Pasieka, Guanmin Chen, Benny So, Adrian Harvey, Alex Chin, Alexander A. Leung
Keywords: diagnosis, screening, care pathway
DOI Number: 10.1001/jamasurg.2021.0254 Publication Year: 2021
To search for other research papers by topic, keyword, author, or year, please go to our Publications page.